JPMorgan Reiterates Overweight Rating on Acadia Pharmaceuticals (ACAD)
Go back to JPMorgan Reiterates Overweight Rating on Acadia Pharmaceuticals (ACAD)| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 28.38 -1.07 (3.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.45 | 52 Week High | $42.49 | |||
| Open | $29.75 | 52 Week Low | $16.64 | |||
| Day High | $29.75 | P/E | N/A | |||
| Day Low | $28.36 | EPS | $-0.42 | |||
| Volume | 1,507,222 | |||||
